Exchange: NASDAQ·Updated 03:05 PM EDT
DFTX logo

DFTX Definium Therapeutics Inc.

$44.52
$1.25
(2.89%)
Today
Reported EarningsAug 6
Mkt Cap$5.81B
Vol771,846.00

About DFTX

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
41

Bearish Sentiment

How do you feel about DFTX?

Advertisement|Remove ads.